BeStock  
Markets › Compare › NUVB vs LKFT

NUVB vs LKFT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NUVB · Nuvation Bio$4.95 ▼ 3.70%
LKFT · Lakefront Biotherapeutics$29.51 ▲ 0.48%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

64116168220272Oct 7, '25Apr 7, '26Oct 5, '26
  • NUVB +35.2%
  • LKFT -15.5%

Head to head

MetricNUVBLKFT
Price$4.95$29.51
Change today▼ 3.70%▲ 0.48%
Market cap$1.74B$1.93B
Return, 3 months-12.7%-3.5%
Return, year to date-44.8%-9.8%
Return, 1 year+31.3%-17.0%
P/E (TTM)-11.32.9
P/B6.80.5
P/E percentile vs own 5y15th–
Dividend yield––
Revenue growth (YoY, latest qtr)+699.0%–
Net profit growth (YoY)+64.0%–
Gross margin85.2%–
Operating margin-338.7%–
Net margin-325.3%–
Return on equity––
Analyst target vs. price+194.3%+27.1%
Analyst buy share100%50%
RSI (14)2754
30-day volatility48.4%33.5%
Max drawdown, 1 year-57.5%-30.7%
Trend readStrong downtrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LKFT is the largest of the group by market value.
  • NUVB has returned the most over the past year.
  • NUVB carries the lowest trailing P/E.
  • LKFT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top